• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇-2'-碳酸乙酯前药可规避P-糖蛋白介导的细胞外排,以增强药物的细胞毒性。

Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.

作者信息

Tanino Tadatoshi, Nawa Akihiro, Kondo Eisaku, Kikkawa Fumitaka, Daikoku Tohru, Tsurumi Tatsuya, Luo Chenhong, Nishiyama Yukihiro, Takayanagi Yuki, Nishimori Katuhiko, Ichida Seiji, Wada Tetsuyuki, Miki Yasuyoshi, Iwaki Masahiro

机构信息

School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan.

出版信息

Pharm Res. 2007 Mar;24(3):555-65. doi: 10.1007/s11095-006-9171-6.

DOI:10.1007/s11095-006-9171-6
PMID:17245652
Abstract

PURPOSE

The aim of the study was to investigate whether 2'-ethylcarbonate-linked paclitaxel (TAX-2'-Et) circumvents P-glycoprotein (P-gp)-mediated cellular efflux and cytotoxicity enhanced by TAX-2'-Et activation within human culture cells transfected with a rabbit liver carboxylesterase (Ra-CES) cDNA.

MATERIALS AND METHODS

TAX-2'-Et transport was characterized in a human colon carcinoma cell line (Caco-2) and paclitaxel (TAX)-resistant ovarian carcinoma cells (SKOV3/TAX60). Expression of P-gp, multidrug resistance protein (MRP) 2 and Ra-CES was detected by Western blotting. Cytotoxicity against Ra-CES-expressing cells and cellular amount of TAX produced were determined by MTT assay and using HPLC, respectively.

RESULTS

Unlike rhodamine123 and TAX, TAX-2'-Et did not exhibit polarized transport in the Caco-2 cells in the absence or presence of verapamil. P-gp levels were expressed much higher in the SKOV3/ TAX60 cells than in the Caco-2 cells. MRP2 protein was not detectable in the SKOV3/TAX60 cells. Uptake by the SKOV3/TAX60 cells was similar in quantity to the amount internalized by P-gp-negative SKOV3 cells. In the SKOV3/TAX60 cells, cellular uptake of TAX-2'-Et was not altered regardless of the absence or presence of verapamil. The cytotoxicity to the untransfected SKOV3 cells induced by TAX-2'-Et was significantly lower than that induced by TAX. In the Ra-CES-expressing SKOV3 line, the EC50 value of TAX (10.6 nM) was approximately four-fold higher than that of TAX-2'-Et (2.5 nM). Transfection of Ra-CES into another TAX-resistant ovarian carcinoma cells (KOC-7c) conferred a high level of TAX-2'-Et cytotoxicity via prodrug activation. The intracellular levels of TAX produced from TAX-2'-Et in the Ra-CES-positive KOC-7c cells significantly increased compared with the levels seen in exposure of the untransfected KOC-7c cells to TAX.

CONCLUSIONS

TAX-2'-Et can circumvent P-gp-associated cellular efflux of TAX. TAX-2'-Et is converted into TAX by the Ra-CES, supporting its potential use as a theoretical GDEPT strategy for cancer cells expressing high levels of P-gp. The TAX-2'-Et prodrug efficiently increased the amount of intracellular TAX, which mediates tumor cell death.

摘要

目的

本研究旨在探讨2'-碳酸乙酯连接的紫杉醇(TAX-2'-Et)是否能规避P-糖蛋白(P-gp)介导的细胞外排作用,以及在转染兔肝脏羧酸酯酶(Ra-CES)cDNA的人培养细胞中TAX-2'-Et激活后细胞毒性是否增强。

材料与方法

在人结肠癌细胞系(Caco-2)和耐紫杉醇(TAX)的卵巢癌细胞(SKOV3/TAX60)中对TAX-2'-Et的转运进行表征。通过蛋白质印迹法检测P-gp、多药耐药蛋白(MRP)2和Ra-CES的表达。分别采用MTT法和高效液相色谱法测定对表达Ra-CES的细胞的细胞毒性以及产生的TAX的细胞量。

结果

与罗丹明123和TAX不同,无论是否存在维拉帕米,TAX-2'-Et在Caco-2细胞中均未表现出极化转运。SKOV3/TAX60细胞中P-gp水平的表达远高于Caco-2细胞。在SKOV3/TAX60细胞中未检测到MRP2蛋白。SKOV3/TAX60细胞的摄取量与P-gp阴性的SKOV3细胞内化的量相似。在SKOV3/TAX60细胞中,无论是否存在维拉帕米,TAX-2'-Et的细胞摄取均未改变。TAX-2'-Et对未转染的SKOV3细胞的细胞毒性显著低于TAX诱导的细胞毒性。在表达Ra-CES的SKOV3细胞系中,TAX的半数有效浓度(EC50)值(10.6 nM)约为TAX-2'-Et(2.5 nM)的四倍。将Ra-CES转染到另一种耐TAX的卵巢癌细胞(KOC-7c)中通过前药激活赋予了高水平的TAX-2'-Et细胞毒性。与未转染的KOC-7c细胞暴露于TAX时相比,Ra-CES阳性的KOC-7c细胞中由TAX-2'-Et产生的TAX细胞内水平显著增加。

结论

TAX-2'-Et可规避与P-gp相关的TAX细胞外排。TAX-2'-Et被Ra-CES转化为TAX,支持其作为一种针对高表达P-gp的癌细胞的理论基因导向酶解药物前体疗法(GDEPT)策略的潜在用途。TAX-2'-Et前药有效增加了介导肿瘤细胞死亡的细胞内TAX量。

相似文献

1
Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.紫杉醇-2'-碳酸乙酯前药可规避P-糖蛋白介导的细胞外排,以增强药物的细胞毒性。
Pharm Res. 2007 Mar;24(3):555-65. doi: 10.1007/s11095-006-9171-6.
2
Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?基因导向酶前药疗法治疗卵巢癌:GDEPT能否成为一种有前景的卵巢癌治疗方法?
Anticancer Agents Med Chem. 2008 Feb;8(2):232-9. doi: 10.2174/187152008783497000.
3
Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.新型紫杉醇 2'-乙酯前药联合 HSV 扩增子与减毒复制型病毒 HF10(作为辅助病毒)联合系统增强细胞毒性。
Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14.
4
Enzymatic stability of 2'-ethylcarbonate-linked paclitaxel in serum and conversion to paclitaxel by rabbit liver carboxylesterase for use in prodrug/enzyme therapy.2'-碳酸乙酯连接的紫杉醇在血清中的酶稳定性以及兔肝脏羧酸酯酶将其转化为紫杉醇用于前药/酶疗法的研究
Biopharm Drug Dispos. 2008 Jul;29(5):259-69. doi: 10.1002/bdd.611.
5
Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.紫杉醇、多西他赛及新型紫杉烷类药物在人乳腺癌细胞中的转运与细胞毒性
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):95-105. doi: 10.1007/s00210-005-1080-4. Epub 2005 Jul 30.
6
Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.喹啉衍生物KB3-1通过逆转MES-SA/DX5癌细胞中的多药耐药性增强紫杉醇诱导的细胞毒性和细胞周期阻滞。
Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.
7
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.葡萄柚汁和橙汁成分对P-糖蛋白和多药耐药相关蛋白2介导的药物外排的影响。
Br J Pharmacol. 2004 Dec;143(7):856-64. doi: 10.1038/sj.bjp.0706008. Epub 2004 Oct 25.
8
Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.组氨酸二肽前药规避 P-糖蛋白和 MRP2 介导的洛匹那韦外排。
Int J Pharm. 2016 Oct 15;512(1):49-60. doi: 10.1016/j.ijpharm.2016.08.027. Epub 2016 Aug 16.
9
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.纳米颗粒包裹的紫杉醇对P-糖蛋白介导的药物外排的敏感性。
Int J Pharm. 2006 Aug 31;320(1-2):150-6. doi: 10.1016/j.ijpharm.2006.03.045. Epub 2006 Apr 7.
10
Organic anion transporting polypeptide 2-mediated uptake of paclitaxel and 2'-ethylcarbonate-linked paclitaxel in freshly isolated rat hepatocytes.
J Pharm Pharmacol. 2009 Aug;61(8):1029-35. doi: 10.1211/jpp/61.08.0006.

引用本文的文献

1
Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.亲脂性药物缀合物:改善药物药代动力学和治疗特性的工具。
Pharm Res. 2021 Sep;38(9):1497-1518. doi: 10.1007/s11095-021-03093-x. Epub 2021 Aug 31.
2
The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.氟尿苷和吉西他滨的二肽单酯前药 - 口服可给予的核苷类似物的可行性。
Pharmaceuticals (Basel). 2014 Jan 27;7(2):169-91. doi: 10.3390/ph7020169.

本文引用的文献

1
Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells.对紫杉醇和紫杉醇C的浆果赤霉素III核心的C10位点进行单位点化学修饰可减少其与牛脑微血管内皮细胞中P-糖蛋白的相互作用。
Bioorg Med Chem Lett. 2006 Feb;16(3):495-8. doi: 10.1016/j.bmcl.2005.10.063. Epub 2005 Nov 10.
2
MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.多药耐药相关蛋白2(ABCC2)转运紫杉烷类药物并赋予对紫杉醇的抗性,而这两个过程均受到丙磺舒的刺激。
Int J Cancer. 2005 Sep 20;116(5):824-9. doi: 10.1002/ijc.21013.
3
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.
多药转运体MRP4/ABCC4的表达是神经母细胞瘤预后不良的一个标志物,并且在体外赋予对伊立替康的抗性。
Mol Cancer Ther. 2005 Apr;4(4):547-53. doi: 10.1158/1535-7163.MCT-04-0161.
4
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.III类β微管蛋白过表达是卵巢癌患者对紫杉醇耐药的一个主要机制。
Clin Cancer Res. 2005 Jan 1;11(1):298-305.
5
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational application.特定羧酸酯酶抑制剂的特性:用于转化应用的羧酸酯酶抑制剂的开发
Mol Cancer Ther. 2004 Aug;3(8):903-9.
6
Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.人肠上皮Caco-2细胞中差异多药耐药相关蛋白1至6亚型的表达及功能
J Pharmacol Exp Ther. 2004 Nov;311(2):476-84. doi: 10.1124/jpet.104.068775. Epub 2004 Jun 21.
7
Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).喜树碱的膜转运:人P-糖蛋白(ABCB1)和多药耐药相关蛋白2(ABCC2)的促进作用
BMC Med. 2004 May 4;2:16. doi: 10.1186/1741-7015-2-16.
8
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).由乳腺癌耐药蛋白BCRP(ABCG2)介导的多药耐药。
Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938.
9
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance.羧酸酯酶介导的人类肿瘤细胞对CPT-11的致敏作用无法克服ABCG2介导的耐药性。
Mol Pharmacol. 2003 Aug;64(2):279-88. doi: 10.1124/mol.64.2.279.
10
DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo.新型口服紫杉烷类药物DJ-927在体内外均可克服P-糖蛋白介导的多药耐药性。
Cancer Sci. 2003 May;94(5):459-66. doi: 10.1111/j.1349-7006.2003.tb01465.x.